121 related articles for article (PubMed ID: 29149756)
1. Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.
Lorenzo-Luaces L; Amsterdam JD; DeRubeis RJ
J Affect Disord; 2018 Feb; 227():379-383. PubMed ID: 29149756
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
3. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
Lorenzo-Luaces L; Amsterdam JD
Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
[TBL] [Abstract][Full Text] [Related]
4. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
8. Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.
Amsterdam JD; Lorenzo-Luaces L; DeRubeis RJ
Bipolar Disord; 2016 Nov; 18(7):563-570. PubMed ID: 27805299
[TBL] [Abstract][Full Text] [Related]
9. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
[TBL] [Abstract][Full Text] [Related]
10. Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy.
Amsterdam JD; Kim TT
J Clin Psychopharmacol; 2019; 39(4):344-350. PubMed ID: 31205190
[TBL] [Abstract][Full Text] [Related]
11. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
12. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
13. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
[TBL] [Abstract][Full Text] [Related]
14. The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression.
Jones G; Rong C; Vecera CM; Gurguis CI; Chudal R; Khairova R; Leung E; Ruiz AC; Shahani L; Zanetti MV; de Sousa RT; Busatto G; Soares J; Gattaz WF; Machado-Vieira R
J Affect Disord; 2022 Jul; 308():71-75. PubMed ID: 35427708
[TBL] [Abstract][Full Text] [Related]
15. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
17. Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode.
Amsterdam JD; Xu C
Bipolar Disord; 2024 May; 26(3):255-264. PubMed ID: 37749069
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
[TBL] [Abstract][Full Text] [Related]
19. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
Bech P; Lönn SL; Overø KF
J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
[TBL] [Abstract][Full Text] [Related]
20. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
